Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects
By Deena Beasley (Reuters) -Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug…
By Deena Beasley (Reuters) -Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug…
By Kanishka Singh and Sarah N. Lynch WASHINGTON (Reuters) -Vice President JD Vance said on Sunday the U.S. was not…
By Leika Kihara TOKYO (Reuters) -Hiking interest rates only gradually as raw material costs rise could heighten the risk of…
By Amy Lv and Ryan Woo BEIJING (Reuters) -China’s overseas shipments of rare earth magnets halved in May from April,…
By Wen-Yee Lee TAIPEI (Reuters) -Taiwan’s Foxconn and U.S. artificial intelligence chips maker Nvidia are in talks to deploy humanoid…
(Reuters) -BofA Global Research on Friday raised its year-end target for the STOXX 600 index to 530 from 500 on…
(Reuters) -AbbVie said on Wednesday its migraine drug met the main goal and was superior to a widely used generic…
By Ahmed Aboulenein WASHINGTON (Reuters) -U.S. Senate Democrats demanded on Wednesday Health Secretary Robert F. Kennedy Jr. make public the…
By Stephen Nellis SAN FRANCISCO (Reuters) -SandboxAQ, an artificial intelligence startup spun out of Alphabet’s Google and backed by Nvidia,…
By Maria Tsvetkova CAMBRIDGE, Massachusetts (Reuters) -When 35-year-old Oscar Escobar completed his term as the youngest elected mayor in his…